Authors:
KENT SJ
ZHAO A
BEST SJ
CHANDLER JD
BOYLE DB
RAMSHAW IA
Citation: Sj. Kent et al., ENHANCED T-CELL IMMUNOGENICITY AND PROTECTIVE EFFICACY OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VACCINE REGIMEN CONSISTING OF CONSECUTIVE PRIMING WITH DNA AND BOOSTING WITH RECOMBINANT FOWLPOX VIRUS, Journal of virology (Print), 72(12), 1998, pp. 10180-10188